Heidi Henson
2017 - Kura Oncology
In 2017, Heidi Henson earned a total compensation of $896.3K as Chief Financial Officer and Secretary at Kura Oncology, a 31% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,471 |
|---|---|
| Option Awards | $414,870 |
| Salary | $334,100 |
| Other | $10,904 |
| Total | $896,345 |
Henson received $414.9K in option awards, accounting for 46% of the total pay in 2017.
Henson also received $136.5K in non-equity incentive plan, $334.1K in salary and $10.9K in other compensation.
Rankings
In 2017, Heidi Henson's compensation ranked 9,494th out of 14,666 executives tracked by ExecPay. In other words, Henson earned more than 35.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,494 out of 14,666 | 35th |
Division Manufacturing | 3,653 out of 5,772 | 37th |
Major group Chemicals And Allied Products | 1,262 out of 2,075 | 39th |
Industry group Drugs | 1,014 out of 1,731 | 41st |
Industry Pharmaceutical Preparations | 796 out of 1,333 | 40th |
Source: SEC filing on April 26, 2018.
Henson's colleagues
We found two more compensation records of executives who worked with Heidi Henson at Kura Oncology in 2017.